News from NYU Langone Health
Spring Allergy Season Is Here – Minimize Symptoms With This Doctor-Approved Tool Kit. (New York Post)
The (3/17) Kanwaljit Brar, MD, associate professor, Department of Pediatrics, Hassenfeld Children’s Hospital, shares her seasonal allergy management strategies, emphasizing the importance of starting medications early, with options like nasal sprays containing fluticasone or triamcinolone, oral antihistamines such as cetirizine or loratadine, and allergy eye drops like olopatadine.
US Measles Outlook Is So Bad Health Experts Call For Updating Vaccine Guidance. (Ars Technica)
(3/14) Health experts, including Wesley Rogers, MD, clinical assistant professor, Department of Medicine, Division of Infectious Diseases and Immunology, have advised American children to receive two doses of the Measles, Mumps, and Rubella (MMR) vaccine, with the first dose administered between 12 and 15 months and the second between 4 and 6 years, emphasizing that early vaccination for at-risk infants is crucial for their health and the health of those around them.
Fly Safely Amid Measles Outbreak With These Important Travel Tips. (3/12) Measles is spreading across the United States with over 220 cases reported by the CDC, primarily stemming from a Texas outbreak, and Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation said measles is highly contagious, particularly to unvaccinated individuals.
Also reporting is the (3/14).
The Other Vaccine-Preventable Diseases Worrying Doctors Now. (Medscape)
Paywalled* (3/14)* Health officials are concerned that the 222 measles cases reported across at least 12 states as of March 6, including one confirmed death, may signal upcoming outbreaks of other preventable diseases such as polio, rubella, and mumps, with Adam J. Ratner, MD, professor, Departments of Pediatrics, and Microbiology, Hassenfeld Children’s Hospital, saying, “When we start to see a decrease in vaccination rates, measles outbreaks are the first thing you see, and often what follows are the other vaccine-preventable diseases.”
We All Age. This Prince William Native And Harvard Grad Student Is Trying To Make It A Little Easier. (Inside NoVa (VA))
(3/14) Zoe Lewczak, external affairs, NIH RECOVER Initiative, NYU Grossman School of Medicine, is pioneering research on intergenerational housing models to alleviate societal aging burdens, driven by personal experiences with her grandparents’ mobility challenges in Florida and her volunteer work with hospice care; her work is supported by a fellowship with the Foundation for Community Association Research, and she plans to survey Florida community associations to identify practical solutions for seniors, with aspirations to pursue a double doctorate in medicine and social sciences.
Twice The Risk Of Inpatient Complications Seen After Second Hip Fractures. (Healio)
(3/12) A study presented at the American Academy of Orthopaedic Surgeons Annual Meeting on March 10-14, 2025, in San Diego found that patients who experienced a second contralateral hip fracture within five years had twice the rate of inpatient complications compared to those with a single hip fracture, according to Sanjit R. Konda, MD, associate professor, Department of Orthopedic Surgery, Chair, Orthopedic Surgery MediSys Health Network, who said, “When those patients come in, they are sicker. They have developed more comorbidities, and their ambulatory status has decreased significantly.”
Real-World Data Demonstrates Efficacy Of Apretude And Cabenuva In HIV Prevention, Treatment. (Pharmaceutical Executive)
(3/14) GSK’s ViiV Healthcare presented data at the Conference on Retroviruses and Opportunistic Infections showing the long-term efficacy of its long-acting injectables, Apretude and Cabenuva, for HIV prevention and treatment, with Apretude demonstrating over 99% effectiveness in prevention and Cabenuva maintaining high viral suppression rates; Ricky K. Hsu, MD, clinical associate professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, said, “Since ViiV Healthcare’s introduction of long-acting injectables, generating these valuable insights has become more important than ever,” underscoring the importance of real-world evidence in understanding the performance of these therapies over time.
Velcheti Evaluates Activity Of Repotrectinib For ROS1 Fusion–Positive NSCLC. (Targeted Oncology)
(3/15) Vamsidhar Velcheti, MD, professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, discussed a case study involving a 59-year-old woman with ROS1 fusion-positive non-small cell lung cancer, treated with repotrectinib, noting its approval as a frontline therapy due to its potent CNS activity and effectiveness against resistance mutations, and described the TRIDENT-1 trial’s findings that supported the drug’s FDA approval, while also addressing the challenges of managing rare alterations with new drugs and clinical trials available in New York.
FDA Reportedly Raids Manufacturer Of Poppers, An Increasingly Popular Party Drug. (NBC Out)
(3/14) The U.S. Food and Drug Administration has focused on Double Scorpio, an Austin-based manufacturer of poppers, following a search and seizure at their offices, prompting the company to cease all operations, while Joseph J. Palamar, MPH, PhD, associate professor, Department of Population Health, indicated that a survey revealed 18% of over 1,400 New York City nightclub attendees used poppers in the past year, with rising reports of serious health issues linked to the drug, who said, “I’m not saying to use them,” but “if you do use them, do not drink them,” adding “You’ll definitely be poisoned.”
Also reporting is the (3/15).
Pig Kidney Pioneers Talk Next Steps, First-Ever Clinical Trials At Orlando Conference. (Healthcare Brew)
(3/14) At the Lake Nona Impact Forum in Orlando, Florida in February, eGenesis and United Therapeutics Corporation announced FDA approval for their clinical trials of genetically modified pig kidney transplants, with Robert Montgomery, MD, DPhil, the H. Leon Pachter, MD, Professor of Surgery, chair, Department of Surgery, NYU Langone Transplant Institute, highlighting the potential for these trials to transform the organ donation system.
GLP-1 Drugs May Extend Life, Graft Survival For Kidney Transplant Recipients With Diabetes. (Healio)
(3/14) A study led by Babak J. Orandi, MD, PhD, associate professor, Department of Surgery, Division of Transplant Surgery, and Department of Medicine, and Yusi Chen, MHS, Department of Surgery, found that kidney transplant recipients with type 2 diabetes who used GLP-1 receptor agonists experienced a 31% lower mortality rate and a 49% lower incidence of graft loss, with dulaglutide being the most prescribed during the study period.
In The Past Year, There Have Been 70 Cases Of Bird Flu And One Death. (KCBS-TV Los Angeles)
(3/14) Jonathan D. LaPook, MD, the Mebane Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health discussed the CDC’s report of 70 bird flu cases and one death in the U.S., while explaining the significant concern over the virus’s mutation potential to spread more easily among humans, particularly as it has now jumped from poultry to cattle in California, affecting dairy production and prompting biosecurity measures.
Yankees’ Giancarlo Stanton Has Another Injury, This One Chronic. (New Jersey Star-Ledger)
(3/14) New York Yankees designated hitter Giancarlo Stanton is dealing with chronic calf and elbow injuries, with Spencer Stein, MD, assistant professor, Department of Orthopedic Surgery, suggesting surgery as a solution, though Stanton remains uncertain.
The Best Time To Take Iron Supplements, According To Experts. (TODAY)
(3/14) A 2024 study published in JAMA finds that iron deficiency may affect up to 40% of young women in the United States, with Julia Adamian, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, section chief, General Internal Medicine and Clinical Innovation, Tisch Hospital, explaining that heavy periods are a common cause, while noting, “Iron contributes to many (enzyme) reactions and metabolites in our body.”
I’ve Restarted An Unexpected Hobby In My 40s. I Had No Idea How Much It Would Improve My Life. (HuffPost)
(3/15) Adam D. Brown, PsyD, clinical assistant professor, Department of Child and Adolescent Psychiatry, reflects on his experiences at the Andy Kessler Skatepark in New York City, emphasizing its role as a vital social space that promotes community, physical activity, and intergenerational connections, while also introducing the Skate Mind Project to support mental health awareness among skaters.
Can You Get Fit By Only Working Out On Weekends? Here’s What Research Says. (Verywell Health)
(3/14) A 2024 study published in Obesity indicates that “weekend warriors,” who exercise one or two days a week, can achieve similar body fat levels to those who work out regularly, provided they meet the recommended 150 minutes of physical activity weekly, with Gregory Katz, MD, assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, who was not involved with the study, saying, “Doing it clustered in a couple of days together is not better or worse than doing it spread out throughout the week.”
Lizzo Shares How She Overcame ‘Dark, Deep Depression’ – And We All Need To Hear Her Advice. (Well and Good)
(3/15) During her first concert in Los Angeles since 2022 on March 15, Lizzo opened up about overcoming a “dark, deep depression” following a lawsuit from former backup dancers, sharing her journey and advice on mental health with the audience, with Thea Gallagher, PsyD, clinical assistant professor, Department of Psychiatry, emphasizing the importance of celebrities discussing such experiences to normalize depression, saying, “It normalizes the experience of having depression,” noting it says, “‘This can happen to anyone, even to a very successful celebrity.’”
News from NYU Langone Hospital—Brooklyn
Opportunistic CT Bone Density Screening Improves Osteoporosis Screening Rate. (Rheumatology Advisor)
The (3/14) Soterios Gyftopoulos, MD, MBA, professor, Departments of Radiology, and Orthopedic Surgery, chief, radiology, NYU Langone Hospital—Brooklyn, and colleagues report in the Journal of the American College of Radiology that opportunistic CT bone density screening could significantly increase osteoporosis screening rates and reduce medical costs, with data from 2,897,040 Medicare beneficiaries indicating that using noncontrast CT for osteoporosis identification could lead to over $17 million in medical cost avoidance for the study population, and potentially $2.5 billion annually for all 2023 Medicare fee-for-service beneficiaries if any CT was used.
News from NYU Langone Hospital—Long Island
I Swapped Cereal For A High-Protein Breakfast And I’ve Never Felt So Full. (Parade Magazine)
(3/15) Christine Buscemi, registered dietitian nutritionist, NYU Langone Hospital—Long Island, contributed insights on high-protein breakfasts, recommending meals with 20 to 30 grams of protein as beneficial for maintaining satiety and energy levels.
